American Statistical Association
The West of Scotland Coronary Prevention Study, initiated in 1988, was the first major study of a statin in patients without a history of myocardial infarction. The study screened over 105,000 individuals in a primary care setting for CHD risk factors and eventually randomized 6595 middle-aged men into a double blind trial of pravastatin versus placebo. This presentation will describe the results and lessons learned from this trial (both clinical and methodological) and the potential we have demonstrated recently for conducting clinical trials based almost entirely on computerized record linkage to routinely collected electronic health records.
|Date:||Wednesday, April 9, 2008|
|Time:||1:00 - 2:00 P.M.|
Mailman School of Public Health
722 West 168th Street
New York, New York